메뉴 건너뛰기




Volumn 33, Issue 2, 2015, Pages 209-217

Hereditary colorectal cancer syndromes: American society of clinical oncology clinical practice guideline endorsement of familial risk-colorectal cancer: European Society for medical oncology clinical practice guidelines

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; CELECOXIB; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; SULINDAC; ANTINEOPLASTIC AGENT; APC PROTEIN; APC PROTEIN, HUMAN; DNA GLYCOSYLASE MUTY; DNA GLYCOSYLTRANSFERASE;

EID: 84920943765     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2014.58.1322     Document Type: Article
Times cited : (287)

References (37)
  • 1
    • 84885337474 scopus 로고    scopus 로고
    • Familial risk-colorectal cancer: ESMO clinical practice guidelines
    • Balmaña J, Balaguer F, Cervantes A, et al: Familial risk-colorectal cancer: ESMO clinical practice guidelines. Ann Oncol 24:vi73-vi80, 2013 (suppl 6).
    • (2013) Ann Oncol , vol.24 , pp. vi73-vi80
    • Balmaña, J.1    Balaguer, F.2    Cervantes, A.3
  • 3
    • 10744233937 scopus 로고    scopus 로고
    • Revised bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability
    • Umar A, Boland CR, Terdiman JP, et al: Revised Bethesda guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. J Natl Cancer Inst 96:261-268, 2004.
    • (2004) J Natl Cancer Inst , vol.96 , pp. 261-268
    • Umar, A.1    Boland, C.R.2    Terdiman, J.P.3
  • 4
    • 17944362664 scopus 로고    scopus 로고
    • Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer)
    • Hampel H, Frankel WL, Martin E, et al: Screening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer). N Engl J Med 352: 1851-1860, 2005.
    • (2005) N Engl J Med , vol.352 , pp. 1851-1860
    • Hampel, H.1    Frankel, W.L.2    Martin, E.3
  • 5
    • 20244386395 scopus 로고    scopus 로고
    • Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer
    • Piñol V, Castells A, Andreu M, et al: Accuracy of revised Bethesda guidelines, microsatellite instability, and immunohistochemistry for the identification of patients with hereditary nonpolyposis colorectal cancer. JAMA 293:1986-1994, 2005.
    • (2005) JAMA , vol.293 , pp. 1986-1994
    • Piñol, V.1    Castells, A.2    Andreu, M.3
  • 6
    • 0029585997 scopus 로고
    • Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome
    • Aarnio M, Mecklin JP, Aaltonen LA, et al: Life-time risk of different cancers in hereditary non-polyposis colorectal cancer (HNPCC) syndrome. Int J Cancer 64:430-433, 1995.
    • (1995) Int J Cancer , vol.64 , pp. 430-433
    • Aarnio, M.1    Mecklin, J.P.2    Aaltonen, L.A.3
  • 7
    • 70350090521 scopus 로고    scopus 로고
    • Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome
    • Stoffel E, Mukherjee B, Raymond VM, et al: Calculation of risk of colorectal and endometrial cancer among patients with Lynch syndrome. Gastroenterology 137:1621-1627, 2009.
    • (2009) Gastroenterology , vol.137 , pp. 1621-1627
    • Stoffel, E.1    Mukherjee, B.2    Raymond, V.M.3
  • 8
    • 84860605783 scopus 로고    scopus 로고
    • Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: A prospective cohort study
    • Win AK, Young JP, Lindor NM, et al: Colorectal and other cancer risks for carriers and noncarriers from families with a DNA mismatch repair gene mutation: A prospective cohort study. J Clin Oncol 30:958-964, 2012.
    • (2012) J Clin Oncol , vol.30 , pp. 958-964
    • Win, A.K.1    Young, J.P.2    Lindor, N.M.3
  • 9
    • 0034011564 scopus 로고    scopus 로고
    • Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer
    • Järvinen HJ, Aarnio M, Mustonen H, et al: Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology 118:829-834, 2000.
    • (2000) Gastroenterology , vol.118 , pp. 829-834
    • Järvinen, H.J.1    Aarnio, M.2    Mustonen, H.3
  • 10
    • 30944457531 scopus 로고    scopus 로고
    • Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome
    • Schmeler KM, Lynch HT, Chen LM, et al: Prophylactic surgery to reduce the risk of gynecologic cancers in the Lynch syndrome. N Engl J Med 354:261-269, 2006.
    • (2006) N Engl J Med , vol.354 , pp. 261-269
    • Schmeler, K.M.1    Lynch, H.T.2    Chen, L.M.3
  • 11
    • 84875036048 scopus 로고    scopus 로고
    • Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome
    • Win AK, Lindor NM, Winship I, et al: Risks of colorectal and other cancers after endometrial cancer for women with Lynch syndrome. J Natl Cancer Inst 105:274-279, 2013.
    • (2013) J Natl Cancer Inst , vol.105 , pp. 274-279
    • Win, A.K.1    Lindor, N.M.2    Winship, I.3
  • 12
    • 84870747205 scopus 로고    scopus 로고
    • Risks of less common cancers in proven mutation carriers with lynch syndrome
    • Engel C, Loeffler M, Steinke V, et al: Risks of less common cancers in proven mutation carriers with lynch syndrome. J Clin Oncol 30:4409-4415, 2012.
    • (2012) J Clin Oncol , vol.30 , pp. 4409-4415
    • Engel, C.1    Loeffler, M.2    Steinke, V.3
  • 13
    • 14644396669 scopus 로고    scopus 로고
    • Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: The German Hereditary Nonpolyposis Colorectal Cancer Consortium
    • Plaschke J, Engel C, Krüger S, et al: Lower incidence of colorectal cancer and later age of disease onset in 27 families with pathogenic MSH6 germline mutations compared with families with MLH1 or MSH2 mutations: The German Hereditary Nonpolyposis Colorectal Cancer Consortium. J Clin Oncol 22:4486-4494, 2004.
    • (2004) J Clin Oncol , vol.22 , pp. 4486-4494
    • Plaschke, J.1    Engel, C.2    Krüger, S.3
  • 14
    • 33749029656 scopus 로고    scopus 로고
    • Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: A report by the German HNPCC Consortium
    • Goecke T, Schulmann K, Engel C, et al: Genotype-phenotype comparison of German MLH1 and MSH2 mutation carriers clinically affected with Lynch syndrome: A report by the German HNPCC Consortium. J Clin Oncol 24:4285-4292, 2006.
    • (2006) J Clin Oncol , vol.24 , pp. 4285-4292
    • Goecke, T.1    Schulmann, K.2    Engel, C.3
  • 15
    • 0035886698 scopus 로고    scopus 로고
    • MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: A study of hereditary nonpolyposis colorectal cancer families
    • Vasen HF, Stormorken A, Menko FH, et al: MSH2 mutation carriers are at higher risk of cancer than MLH1 mutation carriers: A study of hereditary nonpolyposis colorectal cancer families. J Clin Oncol 19:4074-4080, 2001.
    • (2001) J Clin Oncol , vol.19 , pp. 4074-4080
    • Vasen, H.F.1    Stormorken, A.2    Menko, F.H.3
  • 16
    • 48549099663 scopus 로고    scopus 로고
    • The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations
    • Senter L, Clendenning M, Sotamaa K, et al: The clinical phenotype of Lynch syndrome due to germ-line PMS2 mutations. Gastroenterology 135: 419-428, 2008.
    • (2008) Gastroenterology , vol.135 , pp. 419-428
    • Senter, L.1    Clendenning, M.2    Sotamaa, K.3
  • 17
    • 84905562208 scopus 로고    scopus 로고
    • Consequences of universal MSI/IHC in screening endometrial cancer patients for Lynch syndrome
    • Batte BA, Bruegl AS, Daniels MS, et al: Consequences of universal MSI/IHC in screening endometrial cancer patients for Lynch syndrome. Gynecol Oncol 134:319-325, 2014.
    • (2014) Gynecol Oncol , vol.134 , pp. 319-325
    • Batte, B.A.1    Bruegl, A.S.2    Daniels, M.S.3
  • 18
    • 50049124155 scopus 로고    scopus 로고
    • Extraintestinal manifestations of familial adenomatous polyposis
    • Groen EJ, Roos A, Muntinghe FL, et al: Extraintestinal manifestations of familial adenomatous polyposis. Ann Surg Oncol 15:2439-2450, 2008.
    • (2008) Ann Surg Oncol , vol.15 , pp. 2439-2450
    • Groen, E.J.1    Roos, A.2    Muntinghe, F.L.3
  • 19
    • 33846074011 scopus 로고    scopus 로고
    • Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): A review of the literature
    • Nieuwenhuis MH, Vasen HF: Correlations between mutation site in APC and phenotype of familial adenomatous polyposis (FAP): A review of the literature. Crit Rev Oncol Hematol 61:153-161, 2007.
    • (2007) Crit Rev Oncol Hematol , vol.61 , pp. 153-161
    • Nieuwenhuis, M.H.1    Vasen, H.F.2
  • 20
    • 0037468517 scopus 로고    scopus 로고
    • Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH
    • Sieber OM, Lipton L, Crabtree M, et al: Multiple colorectal adenomas, classic adenomatous polyposis, and germ-line mutations in MYH. N Engl J Med 348:791-799, 2003.
    • (2003) N Engl J Med , vol.348 , pp. 791-799
    • Sieber, O.M.1    Lipton, L.2    Crabtree, M.3
  • 21
    • 33947280508 scopus 로고    scopus 로고
    • Identification of MYH mutation carriers in colorectal cancer: A multicenter, case-control, populationbased study
    • Balaguer F, Castellví-Bel S, Castells A, et al: Identification of MYH mutation carriers in colorectal cancer: A multicenter, case-control, populationbased study. Clin Gastroenterol Hepatol 5:379-387, 2007.
    • (2007) Clin Gastroenterol Hepatol , vol.5 , pp. 379-387
    • Balaguer, F.1    Castellví-Bel, S.2    Castells, A.3
  • 22
    • 84864506477 scopus 로고    scopus 로고
    • Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas
    • Grover S, Kastrinos F, Steyerberg EW, et al: Prevalence and phenotypes of APC and MUTYH mutations in patients with multiple colorectal adenomas. JAMA 308:485-492, 2012.
    • (2012) JAMA , vol.308 , pp. 485-492
    • Grover, S.1    Kastrinos, F.2    Steyerberg, E.W.3
  • 23
    • 20244386256 scopus 로고    scopus 로고
    • Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: Familial colorectal cancer type X
    • Lindor NM, Rabe K, Petersen GM, et al: Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: Familial colorectal cancer type X. JAMA 293:1979-1985, 2005.
    • (2005) JAMA , vol.293 , pp. 1979-1985
    • Lindor, N.M.1    Rabe, K.2    Petersen, G.M.3
  • 24
    • 80052696774 scopus 로고    scopus 로고
    • Fourteen years of evolution of ESMO guidelines: From the minimum recommendations to the consensus conference-derived guidelines
    • Pavlidis N, Stahel R, Hansen H, et al: Fourteen years of evolution of ESMO guidelines: From the minimum recommendations to the consensus conference-derived guidelines. Ann Oncol 22:vi7- vi11, 2011 (suppl 6).
    • (2011) Ann Oncol , vol.22 , pp. vi7-vi11
    • Pavlidis, N.1    Stahel, R.2    Hansen, H.3
  • 25
    • 84867122727 scopus 로고    scopus 로고
    • ESMO consensus guidelines for management of patients with colon and rectal cancer: A personalized approach to clinical decision making
    • Schmoll HJ, Van Cutsem E, Stein A, et al: ESMO consensus guidelines for management of patients with colon and rectal cancer: A personalized approach to clinical decision making. Ann Oncol 23:2479-2516, 2012.
    • (2012) Ann Oncol , vol.23 , pp. 2479-2516
    • Schmoll, H.J.1    Van Cutsem, E.2    Stein, A.3
  • 26
    • 84905595139 scopus 로고    scopus 로고
    • Guidelines on genetic evaluation and management of Lynch syndrome: A consensus statement by the US Multi-Society Task Force on Colorectal Cancer
    • Giardiello FM, Allen JI, Axilbund JE, et al: Guidelines on genetic evaluation and management of Lynch syndrome: A consensus statement by the US Multi-Society Task Force on Colorectal Cancer. Am J Gastroenterol 109:1159-1179, 2014.
    • (2014) Am J Gastroenterol , vol.109 , pp. 1159-1179
    • Giardiello, F.M.1    Allen, J.I.2    Axilbund, J.E.3
  • 27
    • 83955161674 scopus 로고    scopus 로고
    • Longterm effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: An analysis from the CAPP2 randomised controlled trial
    • Burn J, Gerdes AM, Macrae F, et al: Longterm effect of aspirin on cancer risk in carriers of hereditary colorectal cancer: An analysis from the CAPP2 randomised controlled trial. Lancet 378: 2081-2087, 2011.
    • (2011) Lancet , vol.378 , pp. 2081-2087
    • Burn, J.1    Gerdes, A.M.2    Macrae, F.3
  • 28
    • 84889084275 scopus 로고    scopus 로고
    • COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations
    • Makar KW, Poole EM, Resler AJ, et al: COX-1 (PTGS1) and COX-2 (PTGS2) polymorphisms, NSAID interactions, and risk of colon and rectal cancers in two independent populations. Cancer Causes Control 24:2059-2075, 2013.
    • (2013) Cancer Causes Control , vol.24 , pp. 2059-2075
    • Makar, K.W.1    Poole, E.M.2    Resler, A.J.3
  • 29
    • 33947492472 scopus 로고    scopus 로고
    • Cox-2 and cancer chemoprevention: Picking up the pieces
    • Bertagnolli MM: Cox-2 and cancer chemoprevention: Picking up the pieces. Recent Results Cancer Res 174:73-78, 2007.
    • (2007) Recent Results Cancer Res , vol.174 , pp. 73-78
    • Bertagnolli, M.M.1
  • 30
    • 59849129653 scopus 로고    scopus 로고
    • EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome
    • Palomaki GE, McClain MR, Melillo S, et al: EGAPP supplementary evidence review: DNA testing strategies aimed at reducing morbidity and mortality from Lynch syndrome. Genet Med 11:42-65, 2009.
    • (2009) Genet Med , vol.11 , pp. 42-65
    • Palomaki, G.E.1    McClain, M.R.2    Melillo, S.3
  • 31
    • 84867499525 scopus 로고    scopus 로고
    • Identification of Lynch syndrome among patients with colorectal cancer
    • Moreira L, Balaguer F, Lindor N, et al: Identification of Lynch syndrome among patients with colorectal cancer. JAMA 308:1555-1565, 2012.
    • (2012) JAMA , vol.308 , pp. 1555-1565
    • Moreira, L.1    Balaguer, F.2    Lindor, N.3
  • 32
    • 59849108362 scopus 로고    scopus 로고
    • Recommendations from the EGAPP Working Group: Genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives
    • Recommendations from the EGAPP Working Group: Genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives. Genet Med 11:35-41, 2009.
    • (2009) Genet Med , vol.11 , pp. 35-41
  • 33
    • 84863609627 scopus 로고    scopus 로고
    • Identification of individuals at risk for Lynch syndrome using targeted evaluations and genetic testing: National society of genetic counselors and the collaborative group of the americas on inherited colorectal cancer joint practice guideline
    • Weissman SM, Burt R, Church J, et al: Identification of individuals at risk for Lynch syndrome using targeted evaluations and genetic testing: National Society of Genetic Counselors and the Collaborative Group of the Americas on Inherited Colorectal Cancer joint practice guideline. J Genet Couns 21:484-493, 2012.
    • (2012) J Genet Couns , vol.21 , pp. 484-493
    • Weissman, S.M.1    Burt, R.2    Church, J.3
  • 34
    • 58149144567 scopus 로고    scopus 로고
    • Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3= exons of TACSTD1
    • Ligtenberg MJ, Kuiper RP, Chan TL, et al: Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3= exons of TACSTD1. Nat Genet 41:112-117, 2009.
    • (2009) Nat Genet , vol.41 , pp. 112-117
    • Ligtenberg, M.J.1    Kuiper, R.P.2    Chan, T.L.3
  • 35
    • 67650383819 scopus 로고    scopus 로고
    • Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome
    • Niessen RC, Hofstra RM, Westers H, et al: Germline hypermethylation of MLH1 and EPCAM deletions are a frequent cause of Lynch syndrome. Genes Chromosomes Cancer 48:737-744, 2009.
    • (2009) Genes Chromosomes Cancer , vol.48 , pp. 737-744
    • Niessen, R.C.1    Hofstra, R.M.2    Westers, H.3
  • 36
    • 78650692633 scopus 로고    scopus 로고
    • Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: A cohort study
    • Kempers MJ, Kuiper RP, Ockeloen CW, et al: Risk of colorectal and endometrial cancers in EPCAM deletion-positive Lynch syndrome: A cohort study. Lancet Oncol 12:49-55, 2011.
    • (2011) Lancet Oncol , vol.12 , pp. 49-55
    • Kempers, M.J.1    Kuiper, R.P.2    Ockeloen, C.W.3
  • 37
    • 80052479865 scopus 로고    scopus 로고
    • Evaluation of guidelines for management of familial adenomatous polyposis in a multicenter pediatric cohort
    • Munck A, Gargouri L, Alberti C, et al: Evaluation of guidelines for management of familial adenomatous polyposis in a multicenter pediatric cohort. J Pediatr Gastroenterol Nutr 53:296-302, 2011.
    • (2011) J Pediatr Gastroenterol Nutr , vol.53 , pp. 296-302
    • Munck, A.1    Gargouri, L.2    Alberti, C.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.